UAE Meningococcal Vaccines Market Size & Outlook
UAE meningococcal vaccines market, 2018-2030 (US$M)
Related Markets
UAE meningococcal vaccines market highlights
- The UAE meningococcal vaccines market generated a revenue of USD 5.6 million in 2021 and is expected to reach USD 12.6 million by 2030.
- The UAE market is expected to grow at a CAGR of 9.5% from 2022 to 2030.
- In terms of segment, quadrivalent was the largest revenue generating type in 2021.
- Quadrivalent is the most lucrative type segment registering the fastest growth during the forecast period.
Meningococcal vaccines market data book summary
| Market revenue in 2021 | USD 5.6 million |
| Market revenue in 2030 | USD 12.6 million |
| Growth rate | 9.5% (CAGR from 2021 to 2030) |
| Largest segment | Quadrivalent |
| Fastest growing segment | Quadrivalent |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bivalent, Quadrivalent |
| Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
Other key industry trends
- In terms of revenue, UAE accounted for 0.2% of the global meningococcal vaccines market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Turkey meningococcal vaccines market is projected to lead the regional market in terms of revenue in 2030.
- Morocco is the fastest growing regional market in Middle East & Africa and is projected to reach USD 0.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Meningococcal Vaccines Market Scope
Meningococcal Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE meningococcal vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 60.71% in 2021. Horizon Databook has segmented the UAE meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
In UAE, the meningococcal vaccine market is anticipated to witness significant growth owing to factors such as increasing healthcare expenditure and growing strategic initiatives between key players & the government. UAE government allocates a significant share of federal budget to the healthcare sector to provide better healthcare services in the country.
In 2020, UAE allocated 6.89% of federal budget to the healthcare sector. UAE vaccinates 7- to 18-year-old individuals with scheduled meningococcal conjugate vaccine and polysaccharide vaccine. Moreover, under Hajj Vaccination Program, the UAE government offers meningococcal vaccine for Hajj travelers.
In addition, presence of immunization guidelines by the Ministry of Health and Prevention and Department of HealthAbu Dhabi providing in-depth information on meningitis and its vaccines, such as Menactra, Mencevax, Menomune, and Menveo, boost market growth.
Reasons to subscribe to UAE meningococcal vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE meningococcal vaccines market databook
-
Our clientele includes a mix of meningococcal vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE meningococcal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into UAE meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE meningococcal vaccines market size, by type, 2018-2030 (US$M)
UAE Meningococcal Vaccines Market Outlook Share, 2021 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
